| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |